Interventional Cardiology KOL Joins Abiomed
This article was originally published in Clinica
Percutaneous heart pump maker Abiomed has appointed Dr Seth Bilazarian Vice-President of Interventional Cardiology Programs. Bilazarian has over 20 years’ experience practicing interventional cardiology in the cath lab with expertise in hemodynamic support; he has also served as physician advisor to the cardiac device panel of the US FDA. His role at Abiomed includes collaborating with other physicians to develop best practices for use of the company’s Impella platform in Protected PCI and helping the company develop new devices within the platform. Abiomed is currently seeking expanded indications for Impella to include patients suffering cardiogenic shock following acute myocardial infarction or cardiac surgery.